Context: Moderna has been embroiled in a number of high-profile patent disputes over technologies used in Covid-19 mRNA vaccines, including with key competitors Pfizer and BioNTech (February 20, 2026 ip fray article), as well as GlaxoSmithKline (November 9, 2026 ip fray article), CureVac (July 21, 2026 ip fray article) and Arbutus Biopharma (March 4, 2026 ip fray article).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jack
Contact Jack, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack